Inna Sekirov

9.2k total citations · 3 hit papers
52 papers, 6.6k citations indexed

About

Inna Sekirov is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Inna Sekirov has authored 52 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 20 papers in Epidemiology and 12 papers in Molecular Biology. Recurrent topics in Inna Sekirov's work include SARS-CoV-2 and COVID-19 Research (22 papers), COVID-19 Clinical Research Studies (13 papers) and Tuberculosis Research and Epidemiology (12 papers). Inna Sekirov is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (22 papers), COVID-19 Clinical Research Studies (13 papers) and Tuberculosis Research and Epidemiology (12 papers). Inna Sekirov collaborates with scholars based in Canada, United States and United Kingdom. Inna Sekirov's co-authors include B. Brett Finlay, L. Caetano M. Antunes, Shannon Russell, Claudia Lupp, Olivia L. Champion, Mark E. Wickham, Erin C. Gaynor, Bryan Coburn, Yuling Li and Sriram Subramaniam and has published in prestigious journals such as Science, Nature Medicine and Nature Communications.

In The Last Decade

Inna Sekirov

45 papers receiving 6.5k citations

Hit Papers

Gut Microbiota in Health and Disease 2007 2026 2013 2019 2010 2007 2022 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gut Microbiota in Health and Disease
    2010 3.0k citations Inna Sekirov, B. Brett Finlay et al. profile →
  2. Host-Mediated Inflammation Disrupts the Intestinal Microbiota and Promotes the Overgrowth of Enterobacteriaceae
    2007 1.1k citations Claudia Lupp, Mark E. Wickham et al. Cell Host & Microbe profile →
  3. SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex
    2022 408 citations Dhiraj Mannar, James W. Saville et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inna Sekirov Canada 17 4.1k 2.2k 1.2k 946 745 52 6.6k
Mariana X. Byndloss United States 32 3.9k 1.0× 1.4k 0.7× 1.3k 1.1× 943 1.0× 559 0.8× 55 5.9k
Siegfried Hapfelmeier Switzerland 31 4.0k 1.0× 2.0k 0.9× 1.7k 1.4× 1.1k 1.1× 786 1.1× 49 7.7k
L. Caetano M. Antunes Brazil 24 3.5k 0.9× 1.2k 0.5× 909 0.8× 748 0.8× 521 0.7× 53 5.1k
Carles Úbeda Spain 37 5.8k 1.4× 3.3k 1.5× 1.0k 0.8× 745 0.8× 1.1k 1.5× 56 9.3k
Emma Allen‐Vercoe Canada 42 5.8k 1.4× 2.5k 1.1× 1.5k 1.2× 1.2k 1.3× 932 1.3× 143 10.3k
Frédéric A. Carvalho France 23 3.4k 0.8× 1.1k 0.5× 607 0.5× 975 1.0× 969 1.3× 42 5.3k
Benjamin P. Willing Canada 37 4.9k 1.2× 1.7k 0.8× 1.6k 1.3× 1.2k 1.3× 934 1.3× 112 7.7k
Tomomi Kuwahara Japan 28 3.7k 0.9× 1.4k 0.7× 935 0.8× 693 0.7× 760 1.0× 97 6.0k
Tine Rask Licht Denmark 48 5.5k 1.4× 1.3k 0.6× 2.0k 1.7× 1.8k 1.9× 821 1.1× 139 8.7k
Deanna L. Gibson Canada 41 3.2k 0.8× 692 0.3× 1.2k 1.0× 1.1k 1.2× 789 1.1× 75 5.7k

Countries citing papers authored by Inna Sekirov

Since Specialization
Citations

This map shows the geographic impact of Inna Sekirov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inna Sekirov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inna Sekirov more than expected).

Fields of papers citing papers by Inna Sekirov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inna Sekirov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inna Sekirov. The network helps show where Inna Sekirov may publish in the future.

Co-authorship network of co-authors of Inna Sekirov

This figure shows the co-authorship network connecting the top 25 collaborators of Inna Sekirov. A scholar is included among the top collaborators of Inna Sekirov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inna Sekirov. Inna Sekirov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolehmainen, Kathleen, Danielle Jorgensen, Calvin Ka-Fung Lo, et al.. (2025). Series 2: Development of a Multiplex Amplicon Next Generation Sequencing Assay for Rapid Assessment of Resistance-Associated Mutations in M. tuberculosis Clinical Cases. Tropical Medicine and Infectious Disease. 10(7). 194–194.
2.
3.
Colijn, Caroline, et al.. (2024). Early prediction of Mycobacterium tuberculosis transmission clusters using supervised learning models. Scientific Reports. 14(1). 27652–27652. 2 indexed citations
4.
5.
Prystajecky, Natalie, et al.. (2024). Nasopharyngeal angiotensin converting enzyme 2 (ACE2) expression as a risk-factor for SARS-CoV-2 transmission in concurrent hospital associated outbreaks. BMC Infectious Diseases. 24(1). 262–262. 1 indexed citations
6.
Morshed, Muhammad, et al.. (2023). Clinical utility and interpretive guidance for SARS-CoV-2 serological testing. Clinical Microbiology Newsletter. 45(24). 209–218.
7.
Skowronski, Danuta M., Michael A. Irvine, Shin Hye Kim, et al.. (2023). Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada. Canadian Medical Association Journal. 195(42). E1427–E1439. 7 indexed citations
8.
Sharma, Meenu K., Cindi R. Corbett, Heather J. Adam, et al.. (2022). Compilation of 10 Years of MIRU-VNTR Data: Canadian National Tuberculosis Laboratory’s Experience. Canadian Journal of Infectious Diseases and Medical Microbiology. 2022. 1–12.
9.
Mammen, Cherry, et al.. (2022). Mycobacterium fortuitum peritoneal dialysis-related peritonitis in a child: A case report and review of the literature. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 7(2). 125–130. 2 indexed citations
10.
Skowronski, Danuta M., Michael A. Irvine, Shinhye Kim, et al.. (2022). Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada. Canadian Medical Association Journal. 194(47). E1599–E1609. 38 indexed citations
11.
Mannar, Dhiraj, James W. Saville, Xing Zhu, et al.. (2022). SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex. Science. 375(6582). 760–764. 408 indexed citations breakdown →
12.
Irvine, Michael A., Romina C. Reyes, Dale Purych, et al.. (2022). Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada. Frontiers in Immunology. 13. 836449–836449. 8 indexed citations
13.
Sekirov, Inna, Vilte Barakauskas, Janet Simons, et al.. (2021). SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia. Journal of Clinical Virology. 142. 104914–104914. 12 indexed citations
14.
Gibbs, Ebrima, Ana Márquez, Soren Gantt, et al.. (2021). A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG. Journal of Clinical Virology. 146. 105050–105050. 14 indexed citations
15.
Sekirov, Inna, Martin Petric, David S. Lawrence, et al.. (2021). Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodies. Access Microbiology. 3(8). 257–257. 8 indexed citations
16.
Sherwood, Karen, David D. M. Nicholl, Franz Fenninger, et al.. (2021). Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case Report. Frontiers in Immunology. 12. 753558–753558. 2 indexed citations
17.
Lupp, Claudia, Mark E. Wickham, Inna Sekirov, et al.. (2007). Host-Mediated Inflammation Disrupts the Intestinal Microbiota and Promotes the Overgrowth of Enterobacteriaceae. Cell Host & Microbe. 2(3). 204–204. 391 indexed citations
18.
Lupp, Claudia, Mark E. Wickham, Inna Sekirov, et al.. (2007). Host-Mediated Inflammation Disrupts the Intestinal Microbiota and Promotes the Overgrowth of Enterobacteriaceae. Cell Host & Microbe. 2(2). 119–129. 1090 indexed citations breakdown →
19.
Coburn, Bryan, Inna Sekirov, & B. Brett Finlay. (2007). Type III Secretion Systems and Disease. Clinical Microbiology Reviews. 20(4). 535–549. 431 indexed citations
20.
Arikawa, Emi, et al.. (2006). Effects of endothelin receptor blockade on hypervasoreactivity in streptozotocin-diabetic rats: vessel-specific involvement of thromboxane A2. Canadian Journal of Physiology and Pharmacology. 84(8-9). 823–833. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariana X. Byndloss Breakdown of academic impact, for papers by Siegfried Hapfelmeier Breakdown of academic impact, for papers by L. Caetano M. Antunes Breakdown of academic impact, for papers by Carles Úbeda Breakdown of academic impact, for papers by Emma Allen‐Vercoe Breakdown of academic impact, for papers by Frédéric A. Carvalho Breakdown of academic impact, for papers by Benjamin P. Willing Breakdown of academic impact, for papers by Tomomi Kuwahara Breakdown of academic impact, for papers by Tine Rask Licht Breakdown of academic impact, for papers by Deanna L. Gibson
Rankless by CCL
2026